ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Major Changes Being Considered By NCI For FCRA

April 14, 1978

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year

November 29, 1991

House Authorizes $30M For Pediatric Cancer Research.

June 13, 2008

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007